Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for B3GXH2

Entry ID Method Resolution Chain Position Source
AF-B3GXH2-F1 Predicted AlphaFoldDB

No variants for B3GXH2

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for B3GXH2

No associated diseases with B3GXH2

2 regional properties for B3GXH2

Type Name Position InterPro Accession
domain Orotidine 5'-phosphate decarboxylase domain 4 - 225 IPR001754
active_site Orotidine 5'-phosphate decarboxylase, active site 56 - 69 IPR018089

Functions

Description
EC Number 4.1.1.23 Carboxy-lyases
Subcellular Localization
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

No GO annotations of cellular component

Name Definition
No GO annotations for cellular component

1 GO annotations of molecular function

Name Definition
orotidine-5'-phosphate decarboxylase activity Catalysis of the reaction: H(+) + orotidine 5'-phosphate = CO(2) + UMP.

2 GO annotations of biological process

Name Definition
'de novo' pyrimidine nucleobase biosynthetic process The chemical reactions and pathways resulting in the formation of pyrimidine nucleobases, 1,3-diazine, organic nitrogenous bases, beginning with the synthesis of a pyrimidine ring from simpler precursors.
'de novo' UMP biosynthetic process The chemical reactions and pathways resulting in the formation of UMP, uridine monophosphate, starting with the synthesis of (S)-dihydroorotate from bicarbonate; UMP biosynthesis may either occur via reduction by quinone, NAD(+) or oxygen.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MDNKIIVALD YETEYEALSF VDQVDPSLCR VKVGKEMFTT LGTNFVKQLH ERKFDVFLDL
70 80 90 100 110 120
KYHDIPNTVA RAVRSAADLG VWMVDLHASG GLTMMEEAKK ILEPYGKDAP LLIAVTVLTS
130 140 150 160 170 180
MEDLDLLQIG INASPMEQVI RLAHLAQRAG LDGVVCSPQE VEVLRTHCGK DFKLVTPGIR
190 200 210 220
PEGSDVGDQR RIMTPKQAIE TGSDYLVIGR PITQAQDPLS VLKSINASIR